Naftidrofuryl Benta (Naftidrofuryl Oxalate)

The active ingredient, Naftidrofuryl Oxalate, acts as a selective antagonist of 5‑HT₂ receptors on vascular smooth muscle. By blocking serotonin‑induced constriction, it lowers blood viscosity and promotes dilation of small arteries and arterioles, thereby enhancing microcirculatory perfusion in peripheral and cerebral tissues.

Dosing of Naftidrofuryl Benta is individualized. The prescribing clinician determines the appropriate strength, frequency and duration based on the patient’s condition, response to therapy and overall health status. No fixed regimen is provided here.

Safety data for Naftidrofuryl Oxalate in pregnancy and lactation are limited. Because the risk cannot be ruled out, the drug should be used only if the potential benefit justifies the potential risk to the fetus or infant, and under close medical supervision.

To place an order, submit an enquiry on the Naftidrofuryl Benta product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternatives for intermittent claudication are cilostazol and pentoxifylline. Unlike cilostazol, which is a phosphodiesterase‑3 inhibitor, Naftidrofuryl works by blocking 5‑HT₂ receptors, offering a different mechanism that may be preferable in patients who cannot tolerate antiplatelet effects. Pentoxifylline improves blood flow by reducing blood viscosity, similar to Naftidrofuryl, but the two agents differ in receptor targets and side‑effect profiles.

Naftidrofuryl Benta tablets should be stored below 25 °C in a dry place. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

The medication is taken orally as a tablet, usually with a glass of water. It may be taken with or without food, according to the prescribing physician’s instructions. Patients should follow the exact schedule provided by their healthcare professional.

The most critical adverse events include severe hypotension, which can cause dizziness or fainting, and allergic reactions such as rash, angioedema or anaphylaxis. Hepatic dysfunction manifested by elevated liver enzymes or jaundice also requires prompt medical evaluation.

Naftidrofuryl Benta is contraindicated in individuals with known hypersensitivity to Naftidrofuryl Oxalate or any tablet excipients. It should be avoided in patients with severe liver disease, uncontrolled hypertension, or those taking other potent vasodilators that could precipitate dangerous drops in blood pressure.